Boon and bane of remission induction with rituximab in ANCA-associated vasculitis: lessons learned from the RAVE-ITN follow-up study.

J Renal Inj Prev · 2014 · PMC4206041 · PMID 25340156

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Unfortunately, patients receiving RTX maintenance in this study showed a trend to relapse after cessation ( 8 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.